Lilly Plans Mirikizumab Filing For Crohn’s After Phase III Success

 
• By Joseph Haas
  
Lilly logo
Lilly intends to go head-to-head with AbbVie's Skyrizi in IBD
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D